Eiko Lifescience

Market Cap: Micro Cap
Industry: Finance/NBFC
ISIN: INE666Q01016
NSEID:
BSEID: 540204

INR

50.69

1.39 (2.82%)

BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 692

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bajaj Finance

Bajaj Finserv

SBI Life Insuran

P. H. Capital

Life Insurance

I R F C

Joindre Capital

Ceejay Finance

Futuristic Solu

ISL Consulting

Eiko Lifescience

Why is Eiko Lifesciences Ltd ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 3.79%

Flat results in Dec 24

Stock is technically in a Bearish range

The technical trend has deteriorated from Mildly Bearish on 26-Mar-25 and has generated -6.54% returns since then
Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST

With ROE of 2.3, it has a Expensive valuation with a 1.2 Price to Book Value

The stock is trading at a fair value compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -10.62%, its profits have risen by 43% ; the PEG ratio of the company is 8

Below par performance in long term as well as near term

Along with generating -10.62% returns in the last 1 year, the stock has also underperformed BSE 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Finance/NBFC)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Eiko Lifescience for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Eiko Lifescience

-10.73%

-0.19

56.36%

SENSEX

0.45%

0.02

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

102.85%

EBIT Growth (5y)

19.63%

Net Debt to Equity (avg)

Institutional Holding

ROE (avg)

3.79%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.21

EV to EBIT

45.31

EV to EBITDA

27.92

EV to Capital Employed

1.29

EV to Sales

1.42

PEG Ratio

7.97

Dividend Yield

ROCE (Latest)

2.84%

ROE (Latest)

2.27%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET SALES(9M)

At Rs 25.40 cr has Grown at 30.06%

PAT(9M)

Higher at Rs 0.84 Cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Eiko Lifescience

Net Sales - Nine Monthly

At Rs 25.40 cr has Grown at 30.06%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Nine Monthly

Higher at Rs 0.84 Cr

than preceding 12 month period ended Dec 2024 of Rs 0.75 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)